Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial

The Lancet Neurology ◽

10.1016/s1474-4422(11)70012-6 ◽

2011 ◽

Vol 10 (3) ◽

pp. 221-229 ◽

Author(s):

Robert A Hauser ◽

Marc Cantillon ◽

Emmanuelle Pourcher ◽

Federico Micheli ◽

Vincent Mok ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Randomised Trial ◽

Motor Fluctuations ◽

Phase 2 ◽

Download Full-text

Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial

Yearbook of Neurology and Neurosurgery ◽

10.1016/j.yneu.2011.05.051 ◽

2011 ◽

Vol 2011 ◽

pp. 80-82

Author(s):

S. Papapetropoulos

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Randomised Trial ◽

Motor Fluctuations ◽

Phase 2 ◽

Download Full-text

Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial

The Lancet Neurology ◽

10.1016/s1474-4422(15)00144-1 ◽

2015 ◽

Vol 14 (8) ◽

pp. 795-803 ◽

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Randomised Trial ◽

Phase 2 ◽

Double Blind ◽

Early Parkinson’S Disease

Download Full-text

Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial

The Lancet Neurology ◽

10.1016/s1474-4422(14)70148-6 ◽

2014 ◽

Vol 13 (8) ◽

pp. 767-776 ◽

Author(s):

Robert A Hauser ◽

C Warren Olanow ◽

Karl D Kieburtz ◽

Emmanuelle Pourcher ◽

Any Docu-Axelerad ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Randomised Trial ◽

Motor Fluctuations ◽

Download Full-text

Faculty Opinions recommendation of Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725596090.793507964 ◽

2015 ◽

Author(s):

Joseph Jankovic ◽

Mary Ann Thenganatt

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Randomised Trial ◽

Phase 2 ◽

Double Blind ◽

Early Parkinson’S Disease

Download Full-text

Faculty Opinions recommendation of Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995409.793474520 ◽

2013 ◽

Author(s):

Cynthia Comella

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Extended Release ◽

Immediate Release ◽

Motor Fluctuations ◽

Double Blind Trial ◽

Phase 3 ◽

Double Blind ◽

Download Full-text

Adjunct rasagiline to treat Parkinson’s disease with motor fluctuations: a randomized, double-blind study in China

Translational Neurodegeneration ◽

10.1186/s40035-018-0119-7 ◽

2018 ◽

Vol 7 (1) ◽

Author(s):

Zhenxin Zhang ◽

Ming Shao ◽

Shengdi Chen ◽

Chunfeng Liu ◽

Rong Peng ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Motor Fluctuations ◽

Blind Study ◽

Double Blind Study ◽

Download Full-text

P1-067: AMBROXOL AS PHARMACOLOGICAL CHAPERONE TARGETING GBA1 AS A DISEASE MODIFYING TREATMENT FOR PARKINSON'S DISEASE DEMENTIA: A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

Alzheimer s & Dementia ◽

10.1016/j.jalz.2018.06.069 ◽

2006 ◽

Vol 14 (7S_Part_5) ◽

pp. P296-P296

Author(s):

Stephen H. Pasternak ◽

Carolina Silveira ◽

Zhonghan Li ◽

Robert Bartha ◽

Michael Borrie ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Phase 2 ◽

Parkinson’S Disease Dementia ◽

Double Blind ◽

Pharmacological Chaperone ◽

Double Blind Placebo ◽

Disease Modifying ◽

Disease Modifying Treatment

Download Full-text

P2.098 Saflnamide as an adjunct to levodopa signiflcantly improved motor fluctuations in Parkinson's disease: a phase III, randomized, double-blind, placebo-controlled study

Parkinsonism & Related Disorders ◽

10.1016/s1353-8020(09)70449-3 ◽

2009 ◽

Vol 15 ◽

pp. S115

Author(s):

R. Borgohain ◽

J. Szasz ◽

M. Bhatt ◽

S. Rossetti ◽

V. Lucini ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Motor Fluctuations ◽

Phase Iii ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy of opicapone in Parkinson’s disease patients with ‘early’ motor fluctuations: Patient and clinical global impression of change from the BIPARK-I double-blind experience

Journal of the Neurological Sciences ◽

10.1016/j.jns.2019.10.1151 ◽

2019 ◽

Vol 405 ◽

pp. 191-192

Author(s):

F. Rocha ◽

F. Stocchi ◽

A. Lees ◽

J. Ferreira ◽

W. Poewe ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Clinical Global Impression ◽

Motor Fluctuations ◽

Double Blind ◽

Global Impression Of Change

Download Full-text

Pardoprunox as adjunct therapy to levodopa in patients with Parkinson’s disease experiencing motor fluctuations: Results of a double-blind, randomized, placebo-controlled, trial

Parkinsonism & Related Disorders ◽

10.1016/j.parkreldis.2011.12.006 ◽

2012 ◽

Vol 18 (4) ◽

pp. 370-376 ◽

Author(s):

O. Rascol ◽

J. Bronzova ◽

R.A. Hauser ◽

A.E. Lang ◽

C. Sampaio ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Motor Fluctuations ◽

Double Blind ◽

Adjunct Therapy

Download Full-text